Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DSM Submits “Final” GMP Report To FDA; New Quality Systems In Place

Executive Summary

DSM Pharmaceuticals is highlighting new environmental monitoring systems in its response to FDA about recent good manufacturing practices inspections

You may also be interested in...



From DSM to ICN

Former DSM Pharmaceuticals CEO Wesley Wheeler is named North American president of ICN Pharmaceuticals. Company notes that Wheeler has experience with "business turnarounds," cites his tenure at DSM. Wheeler joined the contract manufacturing firm as part of a management overhaul following several problematic FDA inspections. Prior to joining DSM, Wheeler was senior VP-logistics & strategy for GlaxoSmithKline (1"The Pink Sheet" Sept. 30, 2002, p. 30)...

From DSM to ICN

Former DSM Pharmaceuticals CEO Wesley Wheeler is named North American president of ICN Pharmaceuticals. Company notes that Wheeler has experience with "business turnarounds," cites his tenure at DSM. Wheeler joined the contract manufacturing firm as part of a management overhaul following several problematic FDA inspections. Prior to joining DSM, Wheeler was senior VP-logistics & strategy for GlaxoSmithKline (1"The Pink Sheet" Sept. 30, 2002, p. 30)...

Catalytica Expects GMP Problems To Be Resolved During Latter Half Of 2002

DSM Catalytica expects to resolve all GMP problems at its Greenville, N.C. facility in the second half of 2002

Related Content

UsernamePublicRestriction

Register

PS040538

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel